Viewing nowCombinationAlducal Tablet 30/2.5 mg
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.

MFDS item code 202204651 · Approved 2022.12.27 · Insurance code 656005400
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used to manage blood pressure more effectively in cases where blood pressure is not adequately controlled with monotherapy of Pimasartan Potassium.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. No initial dosage adjustment is required for elderly patients aged 70 years or younger. No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dosage adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause severe harm or death to the fetus or newborn if taken during pregnancy, particularly in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the main components or related ingredients of this medication, those who are pregnant or breastfeeding, patients undergoing dialysis, patients with moderate to severe liver dysfunction, patients with biliary obstruction, and patients with certain kidney diseases or diabetes should not take this medication. Patients who are hypovolemic or hyponatremic, have impaired renal function, renal artery stenosis, aortic stenosis, severe hypotension, elderly patients, etc., should be administered this medication with special caution, closely monitoring their condition. This medication may cause side effects such as dizziness, headache, facial edema, urination disorders, insomnia, and flushing; consult a doctor or pharmacist if any abnormal symptoms occur. While using this medication, there may be occurrences of hypotension or electrolyte imbalances, so blood pressure and electrolyte levels should be closely monitored, especially when taking diuretics or in cases of diarrhea or vomiting. This medication can elevate potassium levels, so patients with heart failure or chronic kidney disease should have their serum potassium levels checked regularly. There may be interactions when taken with other antihypertensives or specific medications, so it is essential to inform healthcare providers of any medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should discontinue breastfeeding or consult a doctor when taking this medication. The safety and effectiveness in children and adolescents under 18 years have not been established, so use is not recommended. Elderly patients may have heightened sensitivity to this medication and should be cautious when taking it. Patients with moderate to severe liver dysfunction should not take this medication. Overdosage may result in serious symptoms such as hypotension, cardiac arrhythmias, or shock, requiring immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that protects it from light and kept at room temperature between 1 degree and 30 degrees Celsius. Doing so will help maintain the medication's effectiveness for a long time.
White biconvex square film-coated tablets
Bottle pack - 30 tablets/bottle, bottle pack - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Korea Hutech Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.